Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era

Radiotherapy (RT) is an effective and available local treatment for patients with refractory or relapsed (R/R) aggressive B-cell lymphomas. However, the value of hypofractionated RT in this setting has not bee...

Source: BMC Cancer - January 13, 2024 Category: Cancer & Oncology Authors: Cheng Huang, Tian-Lan Tang, Yan-Yan Qiu, Yu-Ping Lin, Si-Lin Chen, Rui-Zhi Zhao, Gui-Qing Shi, Si-Qin Liao, Jin-Hua Chen, Hai-Ying Fu, Jian-Zhi Liu, Ben-Hua Xu, Ting-Bo Liu and Yong Yang Tags: Research Source Type: research